ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,405Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 761

$415K Total Retail Price of All Prescriptions

Rank: 194 out of 761

340 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 340 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

19% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,210 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
OMEPRAZOLE 437 393 1 4
LISINOPRIL 359 328 2 1
LEVOTHYROXINE SODIUM 333 296 3 3
ATENOLOL 320 284 4 8
AMLODIPINE BESYLATE 273 241 5 6
HYDROCHLOROTHIAZIDE 229 214 6 11
HYDROCODONE-ACETAMINOPHEN 215 167 S3 7 5
PRAVASTATIN SODIUM 206 177 8 20
FUROSEMIDE 165 156 9 7
LOVASTATIN 157 157 10 17
SIMVASTATIN 157 145 10 2
LOSARTAN POTASSIUM 139 120 12 13
GABAPENTIN 138 106 13 15
FLUOXETINE HCL 137 98 14 31
POTASSIUM CHLORIDE 134 134 15 18
METFORMIN HCL 129 115 16 10
METOPROLOL SUCCINATE 125 124 17 16
ALLOPURINOL 123 109 18 28
ATORVASTATIN CALCIUM 119 119 19 12
METOPROLOL TARTRATE 119 85 19 14
ZOLPIDEM TARTRATE 112 91 21 22
WARFARIN SODIUM 111 101 22 9
ALENDRONATE SODIUM 106 93 23 21
SERTRALINE HCL 105 83 24 25
OXYCODONE HCL 101 59 S2 25 24
FLUTICASONE PROPIONATE 99 92 26 29
CITALOPRAM HBR 95 60 27 19
ISOSORBIDE MONONITRATE ER 90 85 28 72
CARBIDOPA-LEVODOPA 83 83 29 82
AMITRIPTYLINE HCL 80 69 R 30 54
PAROXETINE HCL 78 48 31 47
KLOR-CON 10 74 63 32 74
TERAZOSIN HCL 72 72 33 86
OXYCODONE-ACETAMINOPHEN 72 69 S2 33 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 68 35 35
TRAMADOL HCL 70 68 35 34
TRAZODONE HCL 67 55 37 23
FENOFIBRATE 66 62 38 91
SPIRONOLACTONE 64 64 39 45
BUPROPION HCL SR 61 36 40 93
CYCLOBENZAPRINE HCL 60 40 R 41 51
CARVEDILOL 58 55 42 26
PREDNISONE 58 51 42 30
DONEPEZIL HCL 56 55 44 33
TRIAMTERENE-HCTZ 56 47 44 42
BENICAR 53 53 46 81
GLIPIZIDE XL 52 52 47 148
OXYBUTYNIN CHLORIDE 52 52 47 85
CLONIDINE HCL 51 51 49 69
DIGOXIN 50 50 50 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.